Starlance Pharmaceuticals

Cefurolens 500 is a prescription antibiotic containing cefuroxime 500 mg, a second-generation cephalosporin known for its broad-spectrum antibacterial activity. It is designed to help treat a wide range of bacterial infections by inhibiting the growth of susceptible bacteria.

Cefurolens 500 is commonly prescribed for infections affecting the respiratory tract, urinary tract, skin and soft tissues, as well as certain ear, nose, and throat infections caused by bacteria sensitive to cefuroxime. It works by interfering with bacterial cell wall synthesis, leading to the elimination of the infection-causing organisms.

This product is formulated to ensure reliable absorption and consistent therapeutic effect when used as directed by a healthcare professional.

Key Features

• Contains Cefuroxime 500 mg

• Broad-spectrum antibacterial action

• Effective against a variety of gram-positive and gram-negative bacteria

• Suitable for multiple types of bacterial infections

Important Information

• Cefurolens 500 is a prescription-only medicine.

• Use only under the supervision of a qualified healthcare professional.

• Not effective against viral infections such as the common cold or flu.

• Patients with known allergy to cephalosporins should consult a doctor before use.

Composition:
Each film-coated tablet contains Cefuroxime Axetil IP equivalent to Cefuroxime 500 mg

Description:
Cefurolens® 500 is a broad-spectrum, second-generation cephalosporin antibiotic formulated to effectively combat a wide range of bacterial infections. Powered by Cefuroxime 500 mg, it works by inhibiting bacterial cell wall synthesis, thereby eliminating susceptible pathogens and preventing further infection spread.

Therapeutic Indications:
Cefurolens® 500 is indicated for the treatment of mild to moderate infections caused by sensitive organisms, including:

• Respiratory tract infections (bronchitis, pneumonia, sinusitis)

• Ear, nose & throat infections

• Urinary tract infections

• Skin and soft tissue infections

• Community-acquired infections as prescribed by physicians

Key Benefits:

• Broad-spectrum antibacterial coverage

• High efficacy against Gram-positive and Gram-negative bacteria

• Well-tolerated with a proven safety profile

• Convenient twice-daily dosing enhances patient compliance

Dosage & Administration:
Dosage should be taken as directed by the physician, depending on the severity and type of infection. It is recommended to take the tablet after meals for optimal absorption.

Storage:
Store in a cool, dry place away from light and moisture. Keep out of reach of children.

Disclaimer:
To be sold by retail on the prescription of a registered medical practitioner only.

Cefpodoxime Proxetil & Clavulanate Potassium Tablets

Pack Size: 10 x 1 x 6 Tablets
Packaging: Alu-Alu Blister Pack

Doxilens CV is a broad-spectrum antibiotic formulation containing Cefpodoxime Proxetil, a third-generation cephalosporin, combined with Clavulanate Potassium, a beta-lactamase inhibitor. This synergistic combination enhances antibacterial efficacy by protecting Cefpodoxime from enzymatic degradation, thereby extending its spectrum of action against resistant bacteria.

The formulation is effective against a wide range of Gram-positive and Gram-negative organisms and is commonly prescribed for various bacterial infections.

Doxilens CV is indicated for the treatment of:

• Upper and lower respiratory tract infections

• Ear, nose, and throat (ENT) infections

• Urinary tract infections (UTIs)

• Skin and soft tissue infections

• Certain gynecological infections

(Use only as directed by a registered medical practitioner.)

✔ Broad-spectrum antibacterial coverage
✔ Enhanced efficacy due to beta-lactamase inhibition
✔ Reliable clinical response
✔ Convenient oral dosage form
✔ Secure Alu-Alu packaging for moisture protection and product stability